The role of carbon ion radiotherapy for unresectable locally recurrent rectal cancer: a single institutional experience
Abstract Background Treatment for locally recurrent rectal cancer after surgery is still a challenge. With the physical and biological advantages, carbon-ion radiotherapy (CIRT) could be a choice for these patients. The purpose of this study was to investigate the efficacy and safety of CIRT for unr...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-08-01
|
Series: | Radiation Oncology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13014-020-01653-w |
id |
doaj-dfefef41201247a5a000e1a8a4dda54a |
---|---|
record_format |
Article |
spelling |
doaj-dfefef41201247a5a000e1a8a4dda54a2020-11-25T03:34:51ZengBMCRadiation Oncology1748-717X2020-08-011511810.1186/s13014-020-01653-wThe role of carbon ion radiotherapy for unresectable locally recurrent rectal cancer: a single institutional experienceXin Cai0Yueyao Du1Zheng Wang2Ping Li3Zhan Yu4Qing Zhang5Zhen Zhang6Department of Radiation Oncology, Shanghai Proton and Heavy Ion CenterDepartment of Breast Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong UniversityDepartment of Radiation Oncology, Shanghai Proton and Heavy Ion CenterDepartment of Radiation Oncology, Shanghai Proton and Heavy Ion CenterDepartment of Radiation Oncology, Shanghai Proton and Heavy Ion CenterDepartment of Radiation Oncology, Shanghai Proton and Heavy Ion CenterShanghai Engineering Research Center of Proton and Heavy Ion Radiation TherapyAbstract Background Treatment for locally recurrent rectal cancer after surgery is still a challenge. With the physical and biological advantages, carbon-ion radiotherapy (CIRT) could be a choice for these patients. The purpose of this study was to investigate the efficacy and safety of CIRT for unresectable locally recurrent rectal cancer in Chinese patients. Methods Date from 25 patients with unresectable locally recurrent rectal cancer treated by CIRT from July 2015 to April 2019 were analyzed retrospectively. The endpoints of this study were overall survival (OS), local control (LC) and acute and late toxicity. Results With the median follow-up of 19.6 (range 5.1–52.5) months, data of all 25 patients were collected. Median prescribed dose for tumor was 72Gy (relative biologic efficacy (RBE)) (range 48–75.6Gy (RBE)). The LC rates at 1 and 2 years were 90.4 and 71.8%. Overall LC at 1- and 2-year were 76.2 and 30.5% for 9 patients whose prescribed tumor doses of CIRT< 66 Gy (RBE), 100 and 100% for 16 patients whose prescribed doses of CIRT≥66 Gy (RBE). Patients received ≥66 Gy (RBE) had obviously better LC rates than those received < 66 Gy (RBE) (P = 0.001). The OS rates at 1 and 2 years were 82.9 and 65.1%, respectively. No acute toxicity over grade 2 was observed, grade 3 late toxicity were observed in 3 patients: gastrointestinal toxicity (n = 1), neuropathy (n = 1), pelvic infection (n = 1). No Grade 4 or higher toxicity was observed. Conclusion Our study shows that CIRT is effective for unresectable locally recurrent rectal cancer patients with acceptable toxicity.http://link.springer.com/article/10.1186/s13014-020-01653-wCarbon-ionRectal cancerPelvic radiationLocal recurrenceParticle therapy |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Xin Cai Yueyao Du Zheng Wang Ping Li Zhan Yu Qing Zhang Zhen Zhang |
spellingShingle |
Xin Cai Yueyao Du Zheng Wang Ping Li Zhan Yu Qing Zhang Zhen Zhang The role of carbon ion radiotherapy for unresectable locally recurrent rectal cancer: a single institutional experience Radiation Oncology Carbon-ion Rectal cancer Pelvic radiation Local recurrence Particle therapy |
author_facet |
Xin Cai Yueyao Du Zheng Wang Ping Li Zhan Yu Qing Zhang Zhen Zhang |
author_sort |
Xin Cai |
title |
The role of carbon ion radiotherapy for unresectable locally recurrent rectal cancer: a single institutional experience |
title_short |
The role of carbon ion radiotherapy for unresectable locally recurrent rectal cancer: a single institutional experience |
title_full |
The role of carbon ion radiotherapy for unresectable locally recurrent rectal cancer: a single institutional experience |
title_fullStr |
The role of carbon ion radiotherapy for unresectable locally recurrent rectal cancer: a single institutional experience |
title_full_unstemmed |
The role of carbon ion radiotherapy for unresectable locally recurrent rectal cancer: a single institutional experience |
title_sort |
role of carbon ion radiotherapy for unresectable locally recurrent rectal cancer: a single institutional experience |
publisher |
BMC |
series |
Radiation Oncology |
issn |
1748-717X |
publishDate |
2020-08-01 |
description |
Abstract Background Treatment for locally recurrent rectal cancer after surgery is still a challenge. With the physical and biological advantages, carbon-ion radiotherapy (CIRT) could be a choice for these patients. The purpose of this study was to investigate the efficacy and safety of CIRT for unresectable locally recurrent rectal cancer in Chinese patients. Methods Date from 25 patients with unresectable locally recurrent rectal cancer treated by CIRT from July 2015 to April 2019 were analyzed retrospectively. The endpoints of this study were overall survival (OS), local control (LC) and acute and late toxicity. Results With the median follow-up of 19.6 (range 5.1–52.5) months, data of all 25 patients were collected. Median prescribed dose for tumor was 72Gy (relative biologic efficacy (RBE)) (range 48–75.6Gy (RBE)). The LC rates at 1 and 2 years were 90.4 and 71.8%. Overall LC at 1- and 2-year were 76.2 and 30.5% for 9 patients whose prescribed tumor doses of CIRT< 66 Gy (RBE), 100 and 100% for 16 patients whose prescribed doses of CIRT≥66 Gy (RBE). Patients received ≥66 Gy (RBE) had obviously better LC rates than those received < 66 Gy (RBE) (P = 0.001). The OS rates at 1 and 2 years were 82.9 and 65.1%, respectively. No acute toxicity over grade 2 was observed, grade 3 late toxicity were observed in 3 patients: gastrointestinal toxicity (n = 1), neuropathy (n = 1), pelvic infection (n = 1). No Grade 4 or higher toxicity was observed. Conclusion Our study shows that CIRT is effective for unresectable locally recurrent rectal cancer patients with acceptable toxicity. |
topic |
Carbon-ion Rectal cancer Pelvic radiation Local recurrence Particle therapy |
url |
http://link.springer.com/article/10.1186/s13014-020-01653-w |
work_keys_str_mv |
AT xincai theroleofcarbonionradiotherapyforunresectablelocallyrecurrentrectalcancerasingleinstitutionalexperience AT yueyaodu theroleofcarbonionradiotherapyforunresectablelocallyrecurrentrectalcancerasingleinstitutionalexperience AT zhengwang theroleofcarbonionradiotherapyforunresectablelocallyrecurrentrectalcancerasingleinstitutionalexperience AT pingli theroleofcarbonionradiotherapyforunresectablelocallyrecurrentrectalcancerasingleinstitutionalexperience AT zhanyu theroleofcarbonionradiotherapyforunresectablelocallyrecurrentrectalcancerasingleinstitutionalexperience AT qingzhang theroleofcarbonionradiotherapyforunresectablelocallyrecurrentrectalcancerasingleinstitutionalexperience AT zhenzhang theroleofcarbonionradiotherapyforunresectablelocallyrecurrentrectalcancerasingleinstitutionalexperience AT xincai roleofcarbonionradiotherapyforunresectablelocallyrecurrentrectalcancerasingleinstitutionalexperience AT yueyaodu roleofcarbonionradiotherapyforunresectablelocallyrecurrentrectalcancerasingleinstitutionalexperience AT zhengwang roleofcarbonionradiotherapyforunresectablelocallyrecurrentrectalcancerasingleinstitutionalexperience AT pingli roleofcarbonionradiotherapyforunresectablelocallyrecurrentrectalcancerasingleinstitutionalexperience AT zhanyu roleofcarbonionradiotherapyforunresectablelocallyrecurrentrectalcancerasingleinstitutionalexperience AT qingzhang roleofcarbonionradiotherapyforunresectablelocallyrecurrentrectalcancerasingleinstitutionalexperience AT zhenzhang roleofcarbonionradiotherapyforunresectablelocallyrecurrentrectalcancerasingleinstitutionalexperience |
_version_ |
1724557079988928512 |